Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Discover the detailed record of transactions filed by Plunkett Matthew. Officer active across 1 company, notably CTI Biopharma CORP. In total, 16 filings have been published. Split: 0 buy · 16 sells. Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Plunkett Matthew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
400 sharesCommon StockSEC:0000891293-16-000094:0
5,000 sharesCommon StockSEC:0000891293-16-000094:1
3,000 sharesCommon StockSEC:0000891293-16-000094:2
600 sharesCommon StockSEC:0000891293-16-000094:3
700 sharesCommon StockSEC:0000891293-16-000094:4
300 sharesCommon StockSEC:0000891293-16-000094:5
1,600 sharesCommon StockSEC:0000891293-16-000079:0
1,898 sharesCommon StockSEC:0000891293-16-000079:1
800 sharesCommon StockSEC:0000891293-16-000079:2
1,900 sharesCommon StockSEC:0000891293-16-000079:3
1,700 sharesCommon StockSEC:0000891293-16-000079:4
800 sharesCommon StockSEC:0000891293-16-000079:5
300 sharesCommon StockSEC:0000891293-16-000079:6
202 sharesCommon StockSEC:0000891293-16-000079:7
600 sharesCommon StockSEC:0000891293-16-000079:8
200 sharesCommon StockSEC:0000891293-16-000079:9
About Plunkett Matthew
Plunkett Matthew is a declarant linked to CTI Biopharma CORP, where he holds the role of EVP, Chief Business Officer. He has filed 16 filings in total, and the recent filings we hold cover the period from 2016-01-06 to 2016-02-05, with the transaction nature indicated as sell.